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Introduction
Patients with chronic kidney failure have disturbances of
immune function involving both innate and adaptive sys-
tems. These result in both immunodepression which in-
creases susceptibility to infection and immunoactivation
leading to a chronic inflammatory state [1]. Dialysis treat-
ment may further aggravate aspects of this, especially the
induction of inflammation. In addition, there is a growing
number of patients who have returned to dialysis pro-
grammes following transplant failure. Many of these will
have been intensively immunosuppressed, often over years
or decades. These patients are at particular risk.
Case report
A 60-year-old haemodialysis (HD) patient was admitted
for investigation of a papulo-nodular rash predominantly
affecting the extensor aspects of both arms (Figure 1).
He had adult polycystic kidney disease and had developed
end-stage renal failure 15 years previously, at which point
he had commenced on HD. He had received a cadaveric
renal transplant 12 years ago which had functioned for
10 years. For the past 2 years, he had been back on HD.
Other past medical history included ischaemic heart dis-
ease, post-transplant diabetes mellitus and hypoadrenalism
secondary to long-term steroid treatment. He had under-
gone splenectomy following abdominal trauma in the past.
Two months prior to this admission, he had been hospital-
ized with abdominal pain and found to have a right para-
colic abscess. This had been treated with drainage and
antibiotics. At the time of this admission, he was receiving
replacement doses of hydrocortisone, tacrolimus having
been discontinued 18 months previously.
Shortly after admission, he sustained a fall. Subsequent
radiographs showed pathological fractures of the right
ankle and of the middle phalanx of the left fifth finger
(Figure 2). A little later, he developed severe rectal bleed-
ing which failed to respond to medical management.
Oesophagogastroduodenoscopy was unremarkable, but
flexible sigmoidoscopy revealed fresh blood extending
to the splenic flexure, suggesting a colonic cause. A mes-
enteric angiogram did not demonstrate active bleeding.
He subsequently underwent sub-total colectomy with res-
olution of the bleeding.
Biopsies of the skin lesions showed non-caseating
granulomata with central microabscesses and rod-like
bacteria which were positive for Ziehl–Neelsen staining.
A mycobacterial species was isolated after 5 days from a
skin biopsy, suggestive of a rapidly growing atypical
mycobacterium. The mycobacterium was subsequently
identified as Mycobacterium chelonae. Histology of the
appendix also demonstrated granulomatous inflammation,
but staining for mycobacteria was negative. The radio-
graphs of the right ankle and left hand were interpreted
as compatible with mycobacterial infection of the bone
causing pathological fracture of the ankle and dactylitis
of the fifth middle finger. A diagnosis of disseminated
atypical mycobacterial disease was made based on proven
Fig. 1. Skin involvement of disseminated disease with M.chelonae
manifesting in papulo-nodular lesions on the forearm.
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skin involvement and probable infection of bone and
appendix. The colon exhibited mucosal ulceration but no
granulomata. Considering the recent diagnosis of a dissem-
inated opportunistic infection, haemorrhagic colitis sec-
ondary to co-existent cytomegalovirus (CMV) infection
was felt to be highly likely. Indeed, CMV polymerase chain
reaction (PCR) using blood was strongly positive.
He was treated with intravenous then oral clarithromycin
and intravenous tobramycin [2]. In addition, he received
intravenous ganciclovir then oral valganciclovir for the
CMV infection. Subsequently, the skin lesions slowly
resolved. There was also healing of the fractures. In addi-
tion, following 2 months of antiviral treatment, the CMV-
PCR became negative. However, 4 months later, the patient
died as a result of dialysis access failure.
Discussion
Infections with atypical mycobacteria, also known as non-
tuberculous mycobacteria, are caused by a wide spectrum
of ubiquitous acid-fast organisms, many of which have only
recently been identified as pathogenic [3]. Infections with
atypical mycobacteria commonly occur in the immunocom-
promised host, but can also manifest in immunocompetent
individuals. The clinical picture varies depending on the
species and includes soft tissue infections, chronic pulmo-
nary and osteo-articular infections as well as disseminated
disease. For many species, there is limited data on which to
base treatment recommendations and the role of antimicro-
bial susceptibility tests is controversial [2]. Multi-drug
combinations are often recommended to avoid emergence
of resistance.
M. chelonae has been associated with disseminated soft
tissue infections, localized cellulitis, osteomyelitis and
catheter infections and appears to have a proclivity for re-
nal transplant patients [4]. Skin biopsies from our patient
clearly demonstrated granuloma with Ziehl–Neelsen posi-
tive rods, and M. chelonae was isolated from two speci-
mens. However, the appendiceal biopsies only showed
granuloma, with the stains being negative for acid-fast
bacilli. This may be explained by the prior exposure of
the tissue to formalin. Indeed, atypical mycobacteria
appear to be more sensitive to decontaminating agents
than tuberculous mycobacteria [5]. Although microbio-
logical or histological evidence for bone involvement
cannot be provided, there is radiological evidence sup-
porting this hypothesis. The lucencies in the right ankle
and left little finger were described as atypical of brown
tumours and in keeping with mycobacterial osteomyelitis.
Despite the limited microbiological evidence for gut and
bone involvement, we still feel this is a distinct possibil-
ity, though we think that the severe haemorrhagic colitis
in this patient was probably related to co-existent CMV
infection. To our knowledge, this would be the first re-
port of infection with M. chelonae affecting these three
organ systems concomitantly.
The risk factors for disseminated infection with atypical
mycobacteria are treatment with immunosuppressant
medication, steroid use and organ transplantation [4],
all of which were present in the patient presented. Further
contributing factors included post-transplant diabetes and
previous splenectomy. The concurrent infection with
CMV further reflects the immunocompromised state of
our patient.
The mode of infection can only be speculated upon.
There are several reports of infections with atypical myco-
bacteria occurring as a consequence of surgical and non-
surgical procedures [6]. In immunocompetent individuals,
infection may occur at the site of trauma or surgery, sug-
gesting reduced local immunity. In our patient, the involve-
ment of the appendix several weeks after radiologically
guided drainage of a paracolic abscess may be attributable
to inoculation with this ubiquitous pathogen which may
then have spread from there.
Antimicrobial treatment of atypical mycobacterial dis-
ease is difficult, particularly in an HD patient. Clarithro-
mycin is the only antibiotic which has been tested in a
clinical trial and shown to be effective in treating dissem-
inated cutaneous disease, albeit with a risk of developing
resistance [7]. Isolates of M. chelonae are generally re-
ported to be highly susceptible to clarithromycin [8] and
tobramycin [9] and less susceptible to imipenem and cipro-
floxacin [10]. The optimal duration of therapy for infec-
tions with atypical mycobacterial bacteria has not been
established. However, the recommended minimal duration
of combination antimicrobial therapy is 4 months for dis-
seminated cutaneous disease and 6 months for osteomy-
elitis [11]. In patients on HD, the antimicrobial treatment
is further complicated by pharmacokinetic alterations
which can influence the efficacy and the duration of
the treatment course and necessitate close monitoring
of the clinical response to ensure effective treatment
and monitoring of antibiotic levels to avoid toxicity.
Teaching points
(1) M. chelonae is a rapidly growing mycobacterium,
associated with disseminated soft tissue infections
and osteomyelitis.
Fig. 2. Radiograph of the left hand demonstrating a pathological fracture
through the middle phalanx of the little finger.
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(2) Risk factors for disseminated infection with atypical
mycobacteria include long-term steroid use and organ
transplantation. In the immunocompetent host, local
infection may be found following trauma or surgery.
(3) Adverse consequences of long-term immunosuppres-
sion may extend for months and even years following
its cessation.
(4) Co-existent opportunistic infections are common. The
finding of one such infection in a patient should alert
to the potential presence of others.
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